Testosterone

Key facts

Active substance
Testosterone
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/161/2009
PIP number
Testosterone
Pharmaceutical form(s)
Transdermal patch
Condition(s) / indication(s)
Hypoactive sexual desire disorder
Route(s) of administration
Transdermal use
Contact for public enquiries
Procter & Gamble Pharmaceuticals UK Ltd
E-mail: Medinfo.im@pg.com
Country: Germany
Phone: +49 1726583443
Fax: +49 6196891378
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Topics

How useful was this page?

Add your rating